<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="http://articles.mercola.com/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>After Vioxx Recall, Other Drugs Under the Microscope</title><link>http://articles.mercola.com/sites/articles/archive/2004/10/20/drug-safety-concerns.aspx</link><description>Since Vioxx's removal from the market, safety concerns on other drugs in its class, known as COX-2 inhibitors, have been raised. With an estimated 30,000 to 100,000 Vioxx users having adverse side effects, including heart attacks and strokes, it's no</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Build: 31106.3070)</generator></channel></rss>